Cases 1 - 10 of 11
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00037
Plaintiff:
Kaken Pharmaceutical Co., LTD., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland LTD and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv00184
Plaintiff:
Kaken Pharmaceutical Co. Ltd., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals North America LLC and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
VIIV Healthcare Company et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2017cv00197
Plaintiff:
VIIV Healthcare Company , Shionogi & Co., LTD., and VIIV Healthcare UK (No. 3) Limited
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Mallinckrodt IP v. Mylan Laboratories Ltd. et al
as 1:2016cv01115
Plaintiff:
Mallinckrodt IP
Defendant:
Mylan Laboratories Ltd. and Agila Specialties Inc.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al
as 2:2016cv00035
Plaintiff:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. , SALIX PHARMACEUTICALS, INC. , PROGENICS PHARMACEUTICALS, INC. and others
Defendant:
MYLAN PHARMACEUTICALS, INC., MYLAN LABORATORIES LTD. and MYLAN INC.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al
as 2:2015cv08180
Defendant:
MYLAN PHARMACEUTICALS, INC., MYLAN INC., ACTAVIS LLC and others
Plaintiff:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC., PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Inc. et al
as 1:2015cv00188
Plaintiff:
Pfizer Inc. , Wyeth LLC , Pfizer Pharmaceuticals LLC and others
Defendant:
Mylan Inc., Mylan N.V., Mylan Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Inc. et al
as 1:2015cv00960
Plaintiff:
Pfizer Inc. , Wyeth LLC , Pfizer Pharmaceuticals LLC and others
Defendant:
Mylan Inc., Mylan N.V., Mylan Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al
as 1:2015cv01402
Plaintiff:
ABBVIE INC. and ABBVIE DEUTSCHLAND GMBH & CO. KG
Defendant:
MYLAN PHARMACEUTICALS INC. , MYLAN LABORATORIES LTD. , MYLAN LABORATORIES INC. and others
Counter_claimant:
MYLAN INC. , MYLAN LABORATORIES LTD. , MYLAN PHARMACEUTICALS INC. and others
Counter_defendant:
ABBVIE DEUTSCHLAND GMBH & CO. KG and ABBVIE INC.
Cause Of Action: 28 U.S.C. § 1331
BAXTER HEALTHCARE CORPORATION et al v. AGILA SPECIALTIES PRIVATE LIMITED et al
as 1:2014cv07094
Plaintiff:
BAXTER HEALTHCARE CORPORATION , BAXTER INTERNATIONAL INC. and BAXTER HEALTHCARE S.A.
Defendant:
AGILA SPECIALTIES INC. , MYLAN PHARMACEUTICALS INC. and MYLAN LABORATORIES LTD.
Counter_claimant:
AGILA SPECIALTIES INC. , AGILA SPECIALTIES PRIVATE LIMITED , MYLAN PHARMACEUTICALS INC. and others
Counter_defendant:
BAXTER HEALTHCARE CORPORATION , BAXTER HEALTHCARE S.A. and BAXTER INTERNATIONAL INC.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
